For patients with degenerated bioprosthetic valves, transcatheter mitral valve-in-valve (MViV) using Sapien 3 (Edwards Lifesciences) provides low rates of mortality and improves heart failure symptoms, now-published data from the Society of Thoracic Surgeons/American College of Cardiology TVT Registry show.
|